Asembia Revenue and Competitors
Estimated Revenue & Valuation
- Asembia's estimated annual revenue is currently $95.1M per year.
- Asembia's estimated revenue per employee is $201,000
Employee Data
- Asembia has 473 Employees.
- Asembia grew their employee count by 2% last year.
Asembia's People
Name | Title | Email/Phone |
---|---|---|
1 | CFO | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | VP, Business Development | Reveal Email/Phone |
4 | VP Operations | Reveal Email/Phone |
5 | VP Controller | Reveal Email/Phone |
6 | VP, Financial Planning & Analysis | Reveal Email/Phone |
7 | VP, Pharmacy Network & Patient Access | Reveal Email/Phone |
8 | VP, clinical solutions and patient access | Reveal Email/Phone |
9 | EVP Manufacturer Relations | Reveal Email/Phone |
10 | VP, Client Services and Patient Access | Reveal Email/Phone |
Asembia Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $375.1M | 1848 | -4% | $1M | N/A |
What Is Asembia?
For more than a decade, Asembia has been working with member pharmacies, manufacturers, prescribers, payers and other industry stakeholders to develop solutions for the high-touch specialty pharmaceutical service model. Through collaborative programs, contracting initiatives, patient support hub services and innovative technology platforms, Asembia is committed to positively impacting the patient journey. asembia.com | asembia1.com | asembiasummit.com
keywords:N/AN/A
Total Funding
473
Number of Employees
$95.1M
Revenue (est)
2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Asembia News
2022-04-17 - HealthWell Foundation to Participate at Asembia's 2022 Specialty Pharmacy
Summit
HealthWell Foundation to Participate at Asembia's 2022 Specialty Pharmacy Summit. Tue, April 19, 2022, 6:00 AM ·3 min read. HealthWell to Moderate Panel and...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $119.4M | 594 | 3% | N/A |
#2 | $200M | 653 | 1% | N/A |
#3 | $163.5M | 730 | 8% | N/A |
#4 | $423.4M | 1205 | -2% | N/A |
#5 | $1063M | 3099 | -8% | N/A |